Pharma Officinalis SRL
Pharma Officinalis reported total assets of €1.83m at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026).
The score of Pharma Officinalis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +41 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Officinalis's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 15 Jul 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
- Year ended 31 Dec 2021filed on 27 Jun 2022
Pharma Officinalis's financial analysis
- Solvency70.9%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Officinalis
Pharma Officinalis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0842.146.872
- VAT number
- BE0842146872
- Peppol
- Registered · 0208:0842146872 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Dec 2011
- Registered office
- 1741 Ternat
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma Officinalis (SRL) has been based in Ternat since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 113,149 € and equity of €1.30m; its revenue is not published. Its solvency stands at 70.9%, above the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma Officinalis
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- SikaCare Retail sale of pharmaceutical products Hasselt · balance sheet €1.82m
- Delputte Marie SRL Retail sale of pharmaceutical products Awans · balance sheet €1.85m
- Fayser Retail sale of pharmaceutical products Pont-à-Celles · balance sheet €1.85m
- Asapharm Retail sale of pharmaceutical products Gembloux · balance sheet €1.86m
- Apotheek Kortessem Retail sale of pharmaceutical products Hasselt · balance sheet €1.86m
- JUVO Retail sale of pharmaceutical products Oudenburg · balance sheet €1.89m
- Duviphar Retail sale of pharmaceutical products Colfontaine · balance sheet €1.76m
Frequently asked questions about Pharma Officinalis
What is the revenue of Pharma Officinalis?
Pharma Officinalis files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Officinalis?
In Belgium, the VAT number is the company number prefixed with BE: BE0842146872 for Pharma Officinalis, if the company is VAT-registered. Its company number (CBE) is 0842.146.872.
Where is the registered office of Pharma Officinalis?
According to the CBE register, the registered office of Pharma Officinalis is in 1741 Ternat.
What is the equity of Pharma Officinalis?
At the close of the 2025 financial year, the equity of Pharma Officinalis amounts to 1,299,097 €, a solvency of 70.9% of total assets.
Who manages Pharma Officinalis?
The register lists 1 active mandates at Pharma Officinalis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Officinalis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →